共 236 条
[1]
Grattagliano I(2012)Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation Clin Biochem 45 610-618
[2]
de Bari O(2011)Mitochondrial dysfunction in nonalcoholic steatohepatitis Expert Rev Gastroenterol Hepatol 5 233-244
[3]
Bernardo TC(2009)Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 19 291-302
[4]
Oliveira PJ(2010)Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease J Mol Med (Berl) 88 993-1001
[5]
Wang DQ(2012)Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects Clin Pharmacokinet 51 553-572
[6]
Portincasa P(2013)Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis Int J Cardiol 167 1892-1899
[7]
Serviddio G(2014)Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes Biochem Pharmacol 92 131-141
[8]
Bellanti F(2010)Fatty liver: role of inflammation and fatty acid nutrition Prostaglandins Leukot Essent Fatty Acids 82 265-271
[9]
Vendemiale G(2007)Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management Nutr Rev 65 376-384
[10]
Altomare E(2012)Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther 36 815-823